Transmission of donor melanoma by organ transplantation

The Lancet Oncology

Volumn 11, Issue 8, 2010, Pages 790-796

  Strauss, Dirk C ^a   Thomas, J Meirion ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

APOPTOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CELL CYCLE ARREST; CELL PROLIFERATION; CHORIOCARCINOMA; DISEASE TRANSMISSION; DNA DETERMINATION; DNA FINGERPRINTING; DORMANCY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GRAFT REJECTION; HLA TYPING; HUMAN; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MELANOMA; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

DONOR SELECTION; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MELANOMA; NEOPLASTIC CELLS, CIRCULATING; ORGAN TRANSPLANTATION; RECURRENCE; SKIN NEOPLASMS;

EID: 77955268790     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70024-3     Document Type: Review

References (56)

1. Alexander JW, Zola JC Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant 1996, 10:1-19.
2. Lutz J, Heemann U Tumours after kidney transplantation. Curr Opin Urol 2003, 13:105-109.
3. MacKie RM, Reid R, Junor B Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 2003, 348:567-568.
4. McIntosh DA, McPhaul JJ, Peterson EW, et al. Homotransplantation of a cadaver neoplasm and a renal homograft. JAMA 1965, 192:1171-1173.
5. Martin DC, Rubini M, Rosen VJ Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma. JAMA 1965, 192:752-754.
6. Jeremy D, Farnsworth RH, Robertson MR, et al. Transplantation of malignant melanoma with cadaver kidney. Transplantation 1972, 13:619-620.
7. Peters MS, Stuard ID Metastatic malignant melanoma transplanted via a renal homograft: a case report. Cancer 1978, 41:2426-2430.
8. Fairman RM, Grossman RA, Barker CF, Perloff LJ Inadvertent transplantation of a melanoma. Transplantation 1980, 30:328-330.
9. Wilson LJ, Horvat RT, Tilzer L, et al. Identification of donor melanoma in a renal transplant recipient. Diagn Mol Pathol 1992, 1:266-271.
10. Elder GJ, Hersey P, Branley P Remission of transplanted melanoma-clinical course and tumour cell characterisation. Clin Transplant 1997, 11:565-568.
11. Schmitt C, Cire K, Schattenkirchner S, et al. Highly sensitive DNA typing for detecting tumors transmitted by transplantation. Transpl Int 1998, 11:382-386.
12. Suranyi MG, Hogan PG, Falk MC, et al. Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation 1998, 66:655-661.
13. Stephens JK, Everson GT, Elliott CL, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000, 70:232-236.
14. Morris-Stiff G, Steel A, Savage P, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004, 4:444-446.
15. Zavos G, Papaconstantinou I, Chrisostomidis C, Kostakis A Metastatic melanoma within a transplanted kidney: a case report. Transplant Proc 2004, 36:1411-1412.
16. Cankovic M, Linden MD, Zarbo RJ Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med 2006, 130:529-532.
17. Milton CA, Barbara J, Cooper J, et al. The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant 2006, 20:547-550.
18. Penn I Malignant melanoma in organ allograft recipients. Transplantation 1996, 61:274-278.
19. Kauffman HM, McBride MA, Delmonico FL First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000, 70:1747-1751.
20. Kauffman HM, Cherikh WS, McBride MA, et al. Deceased donors with a past history of malignancy: an Organ Procurement and Transplantation Network/United Network for Organ Sharing update. Transplantation 2007, 84:272-274.
21. Birkeland SA, Storm HH Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 2002, 74:1409-1413.
22. Sheil AG Donor-derived malignancy in organ transplant recipients. Transplant Proc 2001, 33:1827-1829.
23. Buell JF, Beebe TM, Trofe J, et al. Donor transmitted malignancies. Ann Transplant 2004, 9:53-56.
24. Buell JF, Trofe J, Hanaway MJ, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001, 130:660-666.
25. Skin cancer-UK incidence statistics Cancer Research UK, (accessed Sept 3, 2009). http://info.cancerresearchuk.org/cancerstats/types/skin/incidence/#source11.
26. Tahery DP, Moy RL Recurrent malignant melanoma following a 35-year disease-free interval. J Dermatol Surg Oncol 1993, 19:161-163.
27. Aguirre-Ghiso JA Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007, 7:834-846.
28. Alix-Panabieres C, Riethdorf S, Pantel K Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 2008, 14:5013-5021.
29. Mocellin S, Del Fiore P, Guarnieri L, et al. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer 2004, 111:741-745.
30. Mocellin S, Hoon D, Ambrosi A, et al. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006, 12:4605-4613.
31. Scanlon EF, Hawkins RA, Fox WW, Smith WS Fatal homotransplanted melanoma: a case report. Cancer 1965, 18:782-789.
32. Penn I, Hammond W, Brettschneider L, Starzl TE Malignant lymphomas in transplantation patients. Transplant Proc 1969, 1:106-112.
33. The Israel Penn International Transplant Tumor Registry (accessed Sept 3, 2009). http://www.ipittr.org/About.htm.
34. Penn I Transmission of cancer from organ donors. Ann Transplant 1997, 2:7-12.
35. Loren AW, Desai S, Gorman RC, Schuchter LM Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation 2003, 76:741-743.
36. Buell JF, Gross T, Alloway RR, et al. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc 2005, 37:583-584.
37. Crowley NJ, Seigler HF Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg 1990, 212:173-177.
38. Ozsoy Z, Ozyigit MT, Turkaslan T, Gulluoglu MG Ultralate metastasis of cutaneous melanoma. Dermatol Surg 2006, 32:1287-1289.
39. Schmid-Wendtner MH, Baumert J, Schmidt M, et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol 2000, 43:605-609.
40. Tsao H, Cosimi AB, Sober AJ Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 1997, 79:2361-2370.
41. Brauer JA, Wriston CC, Troxel AB, et al. Characteristics associated with early and late melanoma metastases. Cancer 2010, 116:415-423.
42. Townson JL, Chambers AF Dormancy of solitary metastatic cells. Cell Cycle 2006, 5:1744-1750.
43. Naumov GN, MacDonald IC, Chambers AF, Groom AC Solitary cancer cells as a possible source of tumour dormancy?. Semin Cancer Biol 2001, 11:271-276.
44. Udagawa T Tumor dormancy of primary and secondary cancers. APMIS 2008, 116:615-628.
45. Koebel CM, Vermi W, Swann JB, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450:903-907.
46. Sidky YA, Borden EC Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987, 47:5155-5161.
47. Barnhill RL, Piepkorn MW, Cochran AJ, et al. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998, 134:991-994.
48. Barnhill RL The biology of melanoma micrometastases. Recent Results Cancer Res 2001, 158:3-13.
49. Murugkar P, Azawi K, Humzah D The sleeper cells: delayed sentinel lymph node biopsy. J Plast Reconstr Aesthet Surg 2007, 60:1357-1360.
50. Thomas JM Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 2008, 5:18-23.
51. Van Akkooi AC, Rutkowski P, Van der Ploeg IM, et al. Long-term follow-up of patients with minimal sentinel node tumor burden (<0·1 mm) according to Rotterdam criteria: A study of the EORTC Melanoma Group. J Clin Oncol 2009, 27(15 suppl). abstr 9005.
52. De la Monte SM, Moore GW, Hutchins GM Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983, 43:3427-3433.
53. Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer 2006, 106:1624-1633.
54. Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol 1995, 13:1170-1176.
55. Patel SR, Zagars GK, Pisters PW The follow-up of adult soft-tissue sarcomas. Semin Oncol 2003, 30:413-416.
56. Riethdorf S, Wikman H, Pantel K Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008, 123:1991-2006.